PubMed_Structured_Abstracts

Documents (31,958) JSON TSV

source DB	source ID	text	size	updated at	# proj.	# Ann.	updated_at
PubMed	15109448	Genetic study of a large Chinese kindred with von Hippel-Lindau disease. BACKGROUND: Von Hippel-Lindau (VHL) disease is a heraditary cancer syndrome caused by germline mutations of the VHL tumor on th	2.49 KB	2015-11-18	6	4	-
PubMed	15647107	Stable expression of constitutively-activated STAT3 in benign prostatic epithelial cells changes their phenotype to that resembling malignant cells. BACKGROUND: Signal transducers and activators of tr	2.61 KB	2015-11-18	6	3	-
PubMed	15112280	Characterization of FAMPAC, a newly identified human pancreatic carcinoma cell line with a hereditary background. BACKGROUND: A novel pancreatic carcinoma cell line, FAMPAC, was identified from invest	1.73 KB	2015-11-18	13	4	-
PubMed	15657660	Specific enhanced expression of platelet-derived endothelial cell growth factor in submucosa of human colorectal cancer. PURPOSE: Platelet-derived endothelial cell growth factor, identified to be an a	2.27 KB	2015-11-18	6	4	-
PubMed	15126743	Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line. BACKGROUND/OBJECTIVES:	1.7 KB	2015-11-18	5	5	-
PubMed	15133762	5-Fluorouracil or gemcitabine combined with adenoviral-mediated reintroduction of p16INK4A greatly enhanced cytotoxicity in Panc-1 pancreatic adenocarcinoma cells. BACKGROUND: Pancreatic cancer is one	2.87 KB	2015-11-18	6	3	-
PubMed	15674201	VEGF antisense therapy inhibits tumor growth and improves survival in experimental pancreatic cancer. BACKGROUND: Vascular endothelial growth factor (VEGF), a key mediator of angiogenesis, is overexpr	2.01 KB	2015-11-18	6	4	-
PubMed	15141012	Antisense oligonucleotides directed at the bcl-xl gene product augment chemotherapy response in mesothelioma. OBJECTIVE: Malignant pleural mesothelioma (MPM) is resistant to both conventional chemothe	2 KB	2015-11-18	7	4	-
PubMed	15691303	Esomeprazole 40 mg twice daily in triple therapy and the efficacy of Helicobacter pylori eradication related to CYP2C19 metabolism. AIM: To determine whether an increased dosage of esomeprazole 40 mg	1.47 KB	2015-11-19	7	4	-
PubMed	15156398	Resistance to chemotherapy-induced apoptosis via decreased caspase-3 activity and overexpression of antiapoptotic proteins in ovarian cancer. GOALS: Resistance to cisplatin is the main reason for trea	1.34 KB	2015-11-19	7	4	-